The Role for Osmotic Agents in Children with Acute Encephalopathies: A Systematic Review

Samson Gwer1, Hellen Gatakaa, Leah Mwai

  • 11. Joanna Briggs Institute, Evidence Synthesis Group, Kenya Chapter 2. Centre for Geographic Medicine Research (Coast), KEMRI-Wellcome Trust Collaborative Research Programme, Kenya 3. The International Centre of Insect Physiology and Ecology, Kenya 4. University of Oxford, Nuffield Department of Clinical Medicine, John Radcliffe Hospital, Oxford, UK 5. Department of Paediatrics and Child Health, Mulago Hospital, Makerere University Medical School, Kampala, Uganda 6. London School of Hygiene and Tropical Medicine, London, UK 7. Department of Neurosciences, Child Health Institute, University of London, UK.

JBI Library of Systematic Reviews
|November 8, 2016
PubMed

Insights

Hypertonic saline effectively reduces intracranial pressure (ICP) in children with acute encephalopathies, potentially improving outcomes. Further research is needed to optimize its use and that of other osmotic agents.

Area of Science:

  • Pediatric Neurology
  • Critical Care Medicine
  • Pharmacology

Background:

  • Raised intracranial pressure (ICP) is a critical concern in pediatric acute encephalopathies, potentially leading to severe neurological damage or death.
  • Osmotic agents are standard treatments for elevated ICP, but their application in children often relies on adult-derived evidence.

Purpose of the Study:

  • To systematically review the evidence on the efficacy of various osmotic agents in reducing ICP in children with acute encephalopathies.
  • To assess the impact of these agents on coma resolution, neurological sequelae, and mortality.

Main Methods:

  • A comprehensive literature search was conducted across multiple databases for studies published between 1966 and 2008.
  • Included studies focused on children (0-16 years) with acute encephalopathies treated with osmotic agents.
  • Analysis encompassed randomized controlled trials, observational studies, and case reports.

Main Results:

  • Hypertonic saline demonstrated superior ICP reduction compared to mannitol, normal saline, and Ringer's lactate, especially with continuous infusion.
  • Oral glycerol was linked to reduced mortality and neurological sequelae in pediatric bacterial meningitis.
  • Hypertonic saline showed a survival benefit over mannitol in non-traumatic encephalopathies.

Conclusions:

  • While all agents reduced ICP, sustained reduction requires further investigation into administration methods.
  • Hypertonic saline may enhance cerebral perfusion pressure, a key factor in patient outcomes.
  • Current evidence is insufficient to alter clinical practice, necessitating more research on optimal agent concentrations, routes, and rates.
Abstract

Related Concept Videos

Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
109
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.8K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
622
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
308
Factors Influencing Microbial Growth: Osmolarity01:28

Factors Influencing Microbial Growth: Osmolarity

Osmolarity is the measure of solute concentration in a solution. It plays a critical role in determining water availability for organisms. Water moves across semipermeable membranes through osmosis, flowing from regions of lower solute concentration (more dilute) to regions of higher solute concentration (more concentrated).In high-solute environments, microbial cells lose water, leading to dehydration and inhibited growth. The extent to which water is available to microbes in such environments...
1.2K
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
807